In the planned study, the ClassIntra score will be assessed after all neurosurgical procedures in the upcoming 6 months and correlated with all pre- and postoperative data. Afterwards, the conclusion will be made, if the ClassIntra score could predict the postoperative course of the patients regarding their neurological and general condition. Furthermore, analyses will be made to develop novel postoperative routines adjusted to the individual ClassIntra score of the patient.
Surgeons strive for the best possible outcome of their surgeries with the greatest possible chance for recovery of the patients. Therefore, monitoring and quality improvement is increasingly important in surgery. As there are well-defined scores and classifications to describe the postoperative course regarding morbidity, mortality and neurological status, no validated classification for intraoperative quality exists by now. However, Dell-Kuster et al. introduced a novel classification for assessing all intraoperative adverse events: ClassIntra. This classification was developed in a Delphi consensus containing international, interdisciplinary, and validated in a multicentre cohort study across all surgical disciplines. The classification defines intraoperative adverse events as any deviation from the ideal intraoperative course occurring between skin incision and skin closure and contains any event related to surgery and anaesthesia. Depending on the kind of adverse event, the ClassIntra score ranges from 0 (no event) to 5 (intraoperative death). A prospective study with a main focus on neurosurgery covering the whole spectrum of elective and emergency procedures is needed. Hereby, the outcome parameters need to be defined specific for neurosurgical procedures including a preoperative and postoperative neurological status.
Study Type
OBSERVATIONAL
Enrollment
750
University Medical Center Hamburg-Eppendorf
Hamburg, Hambrug, Germany
RECRUITINGComplications according to Clavien-Dindo classification
Grade 0 to V (0 no complication, V death)
Time frame: within two weeks after surgery
Comprehensive Complication Index
Based on Clavien-Dindo classification with a scale from 0 to 100 (0 no complication, 100 death)
Time frame: within two weeks after surgery
Neurological status
classified to NANO scale, NIHSS, modified Rankin Scale, Glasgow Outcome Scale
Time frame: within two weeks after surgery
Neurological outcome (NANO scale)
according to neurological assessment in neuro-oncology (NANO) with a scale from 0 to 23 (0 no neurological deficit, 23 multiple neurological deficits)
Time frame: within two weeks after surgery
Neurological outcome (NIHSS)
according to National Institutes of Health Stroke Scale (0 no stroke symptoms 1-4 minor stroke 5-15 moderate stroke 16-20 moderate to severe stroke 21-42 severe stroke)
Time frame: within two weeks after surgery
Neurological outcome (mRS)
according to modified Rankin Scale with a scale from 0 to 6 (0 no symptoms, 6 dead)
Time frame: within two weeks after surgery
In-hospital mortality
Death of the patient
Time frame: within two weeks after surgery
Length of ICU stay
Time frame: within two weeks after surgery
Length of hospital stay
Time frame: within two weeks after surgery
Readmission rate
Readmission to hospital after discharge
Time frame: within 90 days after surgery
Lasse Dührsen, MD
CONTACT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.